Validation of the motion sickness severity scale: Secondary analysis of a randomized, double-blind, placebo-controlled study of a treatment for motion sickness.
<h4>Background</h4>Motion sickness is characterized by nausea and vomiting among a constellation of symptoms. Symptom severity is dynamic and distressing. Most validated motion sickness scales are time-intensive and effortful, with alternative scales having uncertain performance or non-s...
Main Authors: | Mark É Czeisler, Justina M Pruski, Pan Wang, Jingyuan Wang, Changfu Xiao, Mihael H Polymeropoulos, Vasilios M Polymeropoulos |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2023-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0280058 |
Similar Items
-
Validation of the motion sickness severity scale: Secondary analysis of a randomized, double-blind, placebo-controlled study of a treatment for motion sickness
by: Mark É. Czeisler, et al.
Published: (2023-01-01) -
Once-daily tasimelteon (VEC-162) for jet lag following transmeridian travel: A multicenter, randomized, double-blind, placebo-controlled trial
by: Christos M. Polymeropoulos, et al.
Published: (2022-09-01) -
Loss-of-function mutations in IFNAR2 in COVID-19 severe infection susceptibility
by: Sandra P. Smieszek, et al.
Published: (2021-09-01) -
Motion sickness: an overview
by: Alexander KC Leung, et al.
Published: (2019-12-01) -
Motion sickness susceptibility and visually induced motion sickness as diagnostic signs in Parkinson’s disease
by: Arthur Petel, et al.
Published: (2022-12-01)